LIBER-CEL

Welcome to the Brand page for “LIBER-CEL”, which is offered here for Pharmaceutical and therapeutic preparations for the treatment of patients with chronic diseases, cancer, kidney disease, diabetes, cachexia, age related sarcopenia, protein-energy wasting, and multiple sclerosis; pharmaceutical and therapeutic preparations for the treatment of autoimmune diseases and disorders;.

Its status is currently believed to be active. Its class is unavailable. “LIBER-CEL” is believed to be currently owned by “Atara Biotherapeutics, Inc.”


Owner:
ATARA BIOTHERAPEUTICS, INC.
Owner Details
Description:
Pharmaceutical and therapeutic preparations for the treatment of patients with chronic diseases, cancer, kidney disease, diabetes, cachexia, age related sarcopenia, protein-energy wasting, and multiple sclerosis; pharmaceutical and therapeutic preparations for the treatment of autoimmune diseases and disorders;
Categories: PHARMACEUTICAL THERAPEUTIC PREPARATIONS